Market Cap : 1.55 M | Enterprise Value : 1.55 M | PE Ratio : | PB Ratio : |
---|
OTCPK:PRTT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OTCPK:PRTT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net margin is calculated as Net Income divided by its Revenue. Protect Pharmaceutical's Net Income for the three months ended in Jun. 2018 was $-0.00 Mil. Protect Pharmaceutical's Revenue for the three months ended in Jun. 2018 was $0.00 Mil. Therefore, Protect Pharmaceutical's net margin for the quarter that ended in Jun. 2018 was 0.00%.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
* The bar in red indicates where Protect Pharmaceutical's Net Margin % falls into.
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Protect Pharmaceutical's Net Margin for the fiscal year that ended in Dec. 2017 is calculated as
Net Margin | = | Net Income (A: Dec. 2017 ) | / | Revenue (A: Dec. 2017 ) |
= | -0.123 | / | 0 | |
= | % |
Protect Pharmaceutical's Net Margin for the quarter that ended in Jun. 2018 is calculated as
Net Margin | = | Net Income (Q: Jun. 2018 ) | / | Revenue (Q: Jun. 2018 ) |
= | -0.004 | / | 0 | |
= | % |
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
No Headline